B
BIO-key International, Inc. (BKYI)
0.57
0.00 (0.00%)

0.57
0.00 (0.00%)
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.26 | 2.38 | 7.0 | |
| Quick ratio | 1.13 | 1.70 | 7.0 | |
| Debt to Equity | 0.24 | -3.94 | 8.0 | |
| Debt to Assets | 0.14 | 0.35 | 8.0 | |
| Interest coverage | -12.19 | 6.05 | 1.0 | |
| Weighted average score | 6.2 | |||
| METRIC | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 5M | 7M | 8M | 7M | 6M |
| Gross Profit | 3M | 5M | 1M | 6M | 5M |
| Operating Income | -5M | -8M | -9M | -4M | -4M |
| Net Income | -5M | -12M | -9M | -4M | -4M |
| EBITDA | -4M | -7M | -8M | -4M | -4M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 50.45 | 86.79 | 10 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | 5.35 | 76.19 | 7.5 |
| Next year | 23.29 | 36 | 10 |
| Weighted average score | 7.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -8.66 | 17.35 | 25 | -27.51 | 5.3 |
| Y/Y | -27.74 | -30.56 | 61.54 | 13.34 | 5.0 |
| 3y average | 12.36 | -19.03 | 12.44 | 30.93 | 6.3 |
| 5y average | 28.5 | 4.84 | 36.17 | -30.68 | 6.3 |
| Weighted average score | 5.7 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $2.0M significantly exceed its total debt $1.5M, ensuring strong financial flexibility
Total current assets $3.7M exceed Total current liabilities $3.0M, highlighting excellent liquidity
Debt-to-equity ratio (0.2) is well below the industry average (-3.9), showcasing prudent financial management
Interest coverage ratio (-12.2x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$1.1M limits the company's ability to reinvest or pay down debt